The IgA myeloma W3129 contains a deletion in CH3 which prevents the formation of the membrane form of heavy chain mRNA
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 25 (5) , 495-503
- https://doi.org/10.1016/0161-5890(88)90170-8
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products.Molecular and Cellular Biology, 1986
- Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre-B cells.Proceedings of the National Academy of Sciences, 1984
- Loss of a consensus splice signal in a mutant immunoglobulin gene eliminates the CH1 domain exon from the mRNA.Molecular and Cellular Biology, 1984
- Molecular characterization of a nonsecreting myeloma mutantEuropean Journal of Immunology, 1983
- Isolation and characterization of a variant of mouse plasmacytoma J558 synthesizing a 110,000-dalton immunoglobulin heavy chain and of secondary variants synthesizing either a 55,000-dalton or an 80,000-dalton immunoglobulin heavy chain: possible implications.Molecular and Cellular Biology, 1982
- Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases.Proceedings of the National Academy of Sciences, 1981
- RNA splicing generates a variant light chain from an aberrantly rearranged κ geneNature, 1980
- Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ endsCell, 1980
- Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybridsCell, 1977
- IMMUNOCHEMICAL STUDIES ON MOUSE MYELOMA PROTEINS REACTIVE WITH DEXTRANS OR WITH FRUCTOSANS AND ON HUMAN ANTILEVANSThe Journal of Experimental Medicine, 1974